{"id":"W4411085883","doi":"10.1002/jha2.70072","title":"Final Results of a Phase 2 Multi‐Arm Study of Magrolimab Combinations in Patients With Relapsed/Refractory Multiple Myeloma","year":2025,"lang":"en","type":"article","venue":"eJHaem","topic":"Multiple Myeloma Research and Treatments","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre; Alberta Cancer Foundation","funders":"National Cancer Institute; Gilead Sciences","keywords":"Daratumumab; Medicine; Pomalidomide; Internal medicine; Dexamethasone; Clinical endpoint; Multiple myeloma; Refractory (planetary science); Neutropenia; Adverse effect; Oncology; Phases of clinical research; Clinical trial; Lenalidomide; Toxicity","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0001796441,0.0001686784,0.000446063,0.0004882296,0.00005165511,0.000005698182,0.0001233863,0.00006346606,0.00002172456],"category_scores_gemma":[0.0005898445,0.0001296636,0.00005622693,0.000585277,0.00009860447,0.00009431852,0.00007069547,0.0002213861,0.000006287177],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001248027,"about_ca_system_score_gemma":0.0001750454,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0005432422,"about_ca_topic_score_gemma":0.0005644428,"domain_scores_codex":[0.9982998,0.000113462,0.0005321857,0.000309617,0.0004793111,0.0002656577],"domain_scores_gemma":[0.9986473,0.0002422041,0.000168405,0.000464387,0.0003742953,0.0001033994],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.01679181,0.07841675,0.8858926,0.0001185876,0.0003071936,0.0001163675,0.001455645,0.000008138668,0.0002528959,0.00002238216,0.0002101164,0.01640747],"study_design_scores_gemma":[0.1879635,0.007095381,0.8021942,0.0002176908,0.00007366581,6.79344e-7,0.0006248456,0.0006028677,0.001054952,0.000008523335,0.00008967487,0.00007398545],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9964804,0.00005266648,0.00002274286,0.00006731442,0.00003982752,0.001724604,0.000116159,0.00002125481,0.001475013],"genre_scores_gemma":[0.9983552,0.000004377411,0.0005832279,0.00001481792,0.000006052886,0.00007856375,0.0001646871,0.00001500451,0.0007780718],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1711717,"threshold_uncertainty_score":0.5287527,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03366329470104022,"score_gpt":0.3353164022583257,"score_spread":0.3016531075572854,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}